Position in JNJ
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$13,001,232
-$264,526 QoQ
Shares Held
51,192
-5.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.46%
of 13F equity value
Holder Rank
#953
of 4,664 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Mar 31, 2025CallValue
$49,215
CallShares
50,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Columbia Asset Management holds $59,491,013 across 10 Drug Manufacturers - General names. JNJ ranks #2 (21.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
110,475 | $14,196,037 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
51,192 | $13,001,232 | |
| 3 | LLY |
ELI LILLY & Co
|
8,009 | $9,606,235 | |
| 4 | ABBV |
AbbVie Inc.
|
34,525 | $8,687,871 | |
| 5 | AMGN |
Amgen Inc
|
21,458 | $7,770,370 | |
| 6 | PFE |
Pfizer Inc
|
190,168 | $4,579,245 | |
| 7 | AZN |
Astrazeneca PLC
|
3,589 | $680,546 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,985 | $377,124 |
All Filings in JNJ
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,001,232 | 51,192 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $13,265,758 | 54,270 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $11,603,479 | 56,069 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $10,551,695 | 56,907 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $8,466,932 | 55,430 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $9,026,671 | 54,430 | Shares | Sole | 2025-04-10 | |
| 2025-03-31 | $49,215 | 50,000 | Call | Sole | 2025-04-10 | |
| 2024-12-31 | $7,968,706 | 55,101 | Shares | Sole | 2025-02-12 | |
| 2024-12-31 | $48,704 | 50,000 | Call | Sole | 2025-02-12 | |
| 2024-09-30 | $9,384,084 | 57,905 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $8,573,014 | 58,655 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $9,183,720 | 58,055 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $9,099,540 | 58,055 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $9,126,638 | 58,598 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $9,846,122 | 59,486 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,152,905 | 59,051 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $10,132,290 | 57,358 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $9,234,087 | 56,526 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $9,873,638 | 55,623 | Shares | Sole | 2022-08-26 | |
| 2021-12-31 | $9,186,459 | 53,700 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,626,845 | 53,417 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,696,130 | 52,787 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $12,223,366 | 74,374 | Shares | Sole | 2021-05-28 | |
| 2020-12-31 | $11,444,516 | 72,719 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $10,760,153 | 72,274 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $10,139,423 | 72,100 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $9,303,017 | 70,945 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||